The opioid crisis has reshaped pain management. Regulators, doctors, and patients face a common challenge: how to ensure that powerful medications reach the people who need them while minimizing misuse, diversion, or accidental exposure. Transdermal systems such as fentanyl patches deliver consistent relief but are vulnerable to abuse. This represents a multi-billion-dollar market that is… Continue reading Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market
Mark MCKelvie
Charting the Intelligence Economy: 4 Companies Transforming Market Data (ATHR, TRI, FDS, NDAQ)
In the modern market, information doesn’t just guide trades; it is the trade. The distance between reading and reacting has collapsed to milliseconds, and in that blur, data itself has become the most valuable asset on the screen. Artificial intelligence is turning every article, comment, and market signal into a feedback loop of prediction. The… Continue reading Charting the Intelligence Economy: 4 Companies Transforming Market Data (ATHR, TRI, FDS, NDAQ)
$550 Billion and Rising: 4 Drone Companies Defining the Next Decade of Autonomy (ZENA, ONDS, KTOS, DPRO)
Autonomy is no longer the future, it’s taking flight today. Across American skies, drones are inspecting bridges, surveying power lines, securing borders, and mapping cities in a single pass. What began as a hobbyist toy or military experiment has become the backbone of a new industrial era defined by data, precision, and real-time awareness. The… Continue reading $550 Billion and Rising: 4 Drone Companies Defining the Next Decade of Autonomy (ZENA, ONDS, KTOS, DPRO)
4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
As 2025 winds down, the biotechnology sector is heating up, signaling a rare window of opportunity for investors. After a period of uneven performance, the industry is regaining momentum, with the global biotech market projected to grow from $1.74 trillion in 2025 to more than $5 trillion by 2034, reflecting a robust annual growth rate… Continue reading 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
Security Matters PLC (NASDAQ: SMX): Turning Waste Into Proof
For decades, the world has struggled to turn sustainability promises into measurable results. Recycling programs fell short, industrial polymers went untracked, and plastics remained a liability rather than an asset. Governments set targets, and companies pledged billions, yet the frameworks were never built to succeed. The outcome was predictable: recycling rates stalled, incineration rose, and… Continue reading Security Matters PLC (NASDAQ: SMX): Turning Waste Into Proof
ZenaTech, Inc. (NASDAQ: ZENA) Prepares 25 U.S. DaaS Hubs Amid $555 Billion Drone Market Growth
Tens of thousands of drones already crisscross American airspace—delivering packages, inspecting power lines, and surveilling borders. By 2030, that number will multiply. But most of them don’t see, think, or decide. They fly preprogrammed routes, collect raw footage, and rely on human operators and a patchwork of off-the-shelf parts, many sourced from countries the United… Continue reading ZenaTech, Inc. (NASDAQ: ZENA) Prepares 25 U.S. DaaS Hubs Amid $555 Billion Drone Market Growth
Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch
Cancer rarely moves fast. It simmers. In the case of cutaneous T-cell lymphoma, or CTCL, it creeps beneath the skin for years, sometimes decades, before erupting into a full malignancy. Patients endure chronic pain, itching, and lesions while cycling through therapy after therapy, chasing control rather than cure. The condition is rare, devastating, and underserved.… Continue reading Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch
4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
The healthcare sector is witnessing a revolution, driven by rapid advancements in precision oncology and molecular diagnostics. These technologies are transforming cancer detection from invasive procedures to simple blood tests capable of identifying multiple cancers at their earliest, most treatable stages. This isn’t just a medical breakthrough; it’s a potential multi-billion-dollar market opportunity on the… Continue reading 4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
From Fields to Frontlines: 4 Drone Firms Defining a $555 Billion Future
The global drone services market is projected to soar from around $33 billion in 2025 to over $555 billion by 2034, a staggering 16-fold increase fueled by breakthroughs in AI, autonomous systems, and data analytics. Investors looking for the next big wave in technology and defense should pay close attention: drones have evolved from niche… Continue reading From Fields to Frontlines: 4 Drone Firms Defining a $555 Billion Future
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
Skin cancer is rarely viewed as life-changing, but for millions of patients each year, basal cell carcinoma brings a cycle of surgeries, scars, and slow recovery that feels endless. Hospitals are overloaded, dermatologists are booked months in advance, and treatments that remove tumors often leave lasting damage. The challenge is not identifying the cancer; it… Continue reading Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology